glp-1 agonists tirzepatide Stopping Receptor Agonists… Why and How to Plan an “Exit Strategy” for Your Patients Frontiers Decoding GLP-1 Weight Loss Medications

pH = 7,4

Acosta, Andres MD, PhD2

Scientists have studied how certain isolated peptides might support or influence these processes in targeted ways

Visit our Vitamin Shot Menu to learn more.

How often it happens The rates vary by trial and population: 2,3 TRIUMPH-4 (obesity with knee osteoarthritis): 8.8% on 9 mg, 20.9% on 12 mg, 0.7% on placebo TRANSCEND-T2D-1 (type 2 diabetes): 4.5% on 4 mg, 2.3% on 9 mg, 4.4% on 12 mg, 0% on placebo Phase 2 trial (Jastreboff 2023): not reported The TRIUMPH-4 numbers are markedly higher than those of TRANSCEND-T2D-1

This means there's less fluid to moisten the mouth, causing it to dry out